Yu Tony's Form 4 filing
GENELUX Corp (GNLX) · filed Dec 11, 2025
- Accession no.
- 0001493152-25-027338
- Filed
- Dec 11, 2025
- Trade date
- Aug 21-Nov 17, 2025
- Filing delay
- 112 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $16.0K. It was filed 112 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yu TonyCIK 0001937482 | Officer (SVP, Clinical Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | Common Stock | SSaleDisposed | −3,219 | $3.36 | −$10,815.84 | 146,817 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −973 | $5.37 | −$5,225.01 | 145,844 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.